British Journal of Haematology, 0007-1048

Tidskrift

Fler filtreringsmöjligheter
  1. Improved outcome after relapse in children with acute myeloid leukaemia

    Abrahamsson, J., Clausen, N., Gustafsson, G., Hovi, L., Jonmundsson, G., Zeller, B., Forestier, E., Heldrup, J. & Hasle, H., 2007, I : British Journal of Haematology. 136, 2, s. 229-236

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  2. Paediatric B-cell precursor acute lymphoblastic leukaemia with t(1;19)(q23;p13): clinical and cytogenetic characteristics of 47 cases from the Nordic countries treated according to NOPHO protocols.

    Andersen, M. K., Autio, K., Barbany, G., Borgström, G., Cavelier, L., Golovleva, I., Heim, S., Heinonen, K., Hovland, R., Johannsson, J. H., Bertil Johansson, Kjeldsen, E., Nordgren, A., Palmqvist, L. & Forestier, E., 2011, I : British Journal of Haematology. 155, s. 235-243

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. Long term risk of infections in Hodgkin lymphoma long-term survivors.

    Andersson, A., Enblad, G., Gustavsson, A., Erlanson, M., Hagberg, H., Molin, D., Tavelin, B. & Melin, B., 2011, I : British Journal of Haematology. 154, s. 661-663

    Forskningsoutput: TidskriftsbidragLetter

  4. Towards a better understanding and new therapeutics of osteopetrosis.

    Askmyr, M. K., Fasth, A. & Johan Richter, 2008, I : British Journal of Haematology. 140, 6, s. 597-609

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  5. Splenic lymphocyte subtypes in immune thrombocytopenia: increased presence of a subtype of B-regulatory cells

    Aslam, R., Segel, G. B., Burack, R., Spence, S. A., Speck, E. R., Guo, L. & John W Semple, 2016 apr, I : British Journal of Haematology. 173, 1, s. 159-60 2 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized

    Jan Astermark, Petrini, P., Tengborn, L., Schulman, S., Rolf Ljung & Erik Berntorp, 1999, I : British Journal of Haematology. 105, 4, s. 1109-1113

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. Antibodies to factor VIIa in patients with haemophilia and high-responding inhibitors.

    Jan Astermark, Ekman, M. & Erik Berntorp, 2002, I : British Journal of Haematology. 119, 2, s. 342-347

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. Major surgery seems not to influence HIV disease progression in haemophilia patients

    Jan Astermark, Löfqvist, T., Schulman, S., Stigendal, L., Lethagen, S., Nilsson, I. M. & Erik Berntorp, 1998, I : British Journal of Haematology. 103, 1, s. 10-14

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. Age-time risk patterns of solid cancers in 60 901 non-Hodgkin lymphoma survivors from Finland, Norway and Sweden

    Bermejo, J. L., Pukkala, E., Johannesen, T. B., Jan Sundquist & Kari Hemminki, 2014, I : British Journal of Haematology. 164, 5, s. 675-683

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. Monoclonal gammopathy of undetermined significance: to screen or not to screen for multiple myeloma? - response

    Bird, J., Behrens, J., Drayson, M. T., Ingemar Turesson & Westin, J., 2010, I : British Journal of Haematology. 149, 4, s. 621-623

    Forskningsoutput: TidskriftsbidragLetter

  11. UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS)

    Bird, J., Behrens, J., Westin, J., Ingemar Turesson, Drayson, M., Beetham, R., D'Sa, S., Soutar, R., Waage, A., Gulbrandsen, N., Gregersen, H. & Low, E., 2009, I : British Journal of Haematology. 147, 1, s. 22-42

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. Diagnosis of acute promyelocytic leukaemia by RT-PCR: detection of PML-RARA and RARA-PML fusion transcripts

    Borrow, J., Goddard, A. D., Gibbons, B., Katz, F., Swirsky, D., Thoas Fioretos, Dube, I., Winfield, D. A., Kingston, J., Hagemeijer, A., Rees, J. K. H., Lister, T. A. & Solomon, E., 1992, I : British Journal of Haematology. 82, 3, s. 529-540

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. The impact of bleeding history, von Willebrand factor and PFA-100 (R) on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD

    Castaman, G., Tosetto, A., Goodeve, A., Federici, A. B., Lethagen, S., Budde, U., Batlle, J., Meyer, D., Mazurier, C., Goudemand, J., Eikenboom, J., Schneppenheim, R., Ingerslev, J., Habart, D., Hill, F., Peake, I. & Rodeghiero, F., 2010, I : British Journal of Haematology. 151, 3, s. 245-251

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. The addition of etoposide to CHOP is associated with improved outcome in ALK+ adult anaplastic large cell lymphoma: A Nordic Lymphoma Group study

    Henrik Cederleuf, Bjerregård Pedersen, M., Mats Jerkeman, Relander, T., d'Amore, F. & Fredrik Ellin, 2017, I : British Journal of Haematology. 178, 5, s. 739-746

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. Development of Duffy transgenic mouse: in vivo expression of human Duffy gene with -33T -> C promoter mutation in non-erythroid tissues

    Chaudhuri, A., Yuen, G., Fang, F. & Jill Storry, 2004, I : British Journal of Haematology. 127, 3, s. 356-359

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. Verification that common variation at 2q37.1, 6p25.3, 11q24.1, 15q23, and 19q13.32 influences chronic lymphocytic leukaemia risk

    Crowther-Swanepoel, D., Mansouri, M., Enjuanes, A., Vega, A., Smedby, K. E., Ruiz-Ponte, C., Jurlander, J., Gunnar Juliusson, Montserrat, E., Catovsky, D., Campo, E., Carracedo, A., Rosenquist, R. & Houlston, R. S., 2010, I : British Journal of Haematology. 150, 4, s. 473-479

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma

    d'Amore, F., Radford, J., Relander, T., Mats Jerkeman, Tilly, H., Osterborg, A., Morschhauser, F., Gramatzki, M., Dreyling, M., Bang, B. & Hagberg, H., 2010, I : British Journal of Haematology. 150, 5, s. 565-573

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma

    Dang, N. H., Ogura, M., Castaigne, S., Fayad, L. E., Mats Jerkeman, Radford, J., Pezzutto, A., Bondarenko, I. N., Stewart, D. A., Shnaidman, M., Sullivan, S., Vandendries, E., Tobinai, K., Ramchandren, R., Hamlin, P. A., Giné, E. & Ando, K., 2018, I : British Journal of Haematology. 182, 4, s. 583-586

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  19. Haematopoietic progenitor cells utilise conventional PKC to suppress PKB/Akt activity in response to c-Kit stimulation

    Edling, C. E., Pedersen, M., Carlsson, L., Lars Rönnstrand, Palmer, R. H. & Hallberg, B., 2007, I : British Journal of Haematology. 136, 2, s. 260-268

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. Clonogenicity, gene expression and phenotype during neutrophil versus erythroid differentiation of cytokine-stimulated CD34 human marrow cells in vitro.

    Edvardsson, L., Dykes, J., Martin L Olsson & Olofsson, T., 2004, I : British Journal of Haematology. 127, 4, s. 451-463

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Föregående 1 2 3 4 5 6 Nästa